Respiratory diseases: Gq protein inhibition induces airway relaxation
Nature Reviews Drug Discovery 16, 752 (2017).
doi:10.1038/nrd.2017.203
Author: Sarah Crunkhorn
Currently available therapies for obstructive airway diseases, such as asthma, bronchitis and chronic obstructive pulmonary diseases (COPD), may be limited by poor disease control, adverse effects or a lack of efficacy. Writing in Science Translational Medicine, Matthey et al. now demonstrate that pharmacological
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Sarah Crunkhorn Tags: Research Highlight Source Type: research
More News: Asthma | Bronchitis | Chronic Obstructive Pulmonary | Drugs & Pharmacology | Respiratory Medicine | Science